STERIS Statistics
Total Valuation
STERIS has a market cap or net worth of $19.75 billion. The enterprise value is $21.39 billion.
| Market Cap | 19.75B |
| Enterprise Value | 21.39B |
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | Jun 8, 2026 |
Share Statistics
STERIS has 97.46 million shares outstanding. The number of shares has decreased by -0.40% in one year.
| Current Share Class | 97.46M |
| Shares Outstanding | 97.46M |
| Shares Change (YoY) | -0.40% |
| Shares Change (QoQ) | -0.20% |
| Owned by Insiders (%) | 0.33% |
| Owned by Institutions (%) | 99.86% |
| Float | 97.04M |
Valuation Ratios
The trailing PE ratio is 25.55 and the forward PE ratio is 18.16.
| PE Ratio | 25.55 |
| Forward PE | 18.16 |
| PS Ratio | 3.33 |
| Forward PS | 3.10 |
| PB Ratio | 2.76 |
| P/TBV Ratio | 14.43 |
| P/FCF Ratio | 20.31 |
| P/OCF Ratio | 14.72 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.39, with an EV/FCF ratio of 22.00.
| EV / Earnings | 27.35 |
| EV / Sales | 3.60 |
| EV / EBITDA | 13.39 |
| EV / EBIT | 19.25 |
| EV / FCF | 22.00 |
Financial Position
The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.29.
| Current Ratio | 2.09 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 1.25 |
| Debt / FCF | 2.15 |
| Interest Coverage | 18.31 |
Financial Efficiency
Return on equity (ROE) is 11.37% and return on invested capital (ROIC) is 9.45%.
| Return on Equity (ROE) | 11.37% |
| Return on Assets (ROA) | 6.65% |
| Return on Invested Capital (ROIC) | 9.45% |
| Return on Capital Employed (ROCE) | 11.59% |
| Weighted Average Cost of Capital (WACC) | 8.64% |
| Revenue Per Employee | $330,930 |
| Profits Per Employee | $43,614 |
| Employee Count | 17,937 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 5.46 |
Taxes
In the past 12 months, STERIS has paid $262.20 million in taxes.
| Income Tax | 262.20M |
| Effective Tax Rate | 25.04% |
Stock Price Statistics
The stock price has decreased by -14.54% in the last 52 weeks. The beta is 0.92, so STERIS's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -14.54% |
| 50-Day Moving Average | 214.58 |
| 200-Day Moving Average | 238.88 |
| Relative Strength Index (RSI) | 38.02 |
| Average Volume (20 Days) | 836,234 |
Short Selling Information
The latest short interest is 1.81 million, so 1.85% of the outstanding shares have been sold short.
| Short Interest | 1.81M |
| Short Previous Month | 1.87M |
| Short % of Shares Out | 1.85% |
| Short % of Float | 1.86% |
| Short Ratio (days to cover) | 2.09 |
Income Statement
In the last 12 months, STERIS had revenue of $5.94 billion and earned $782.30 million in profits. Earnings per share was $7.93.
| Revenue | 5.94B |
| Gross Profit | 2.63B |
| Operating Income | 1.11B |
| Pretax Income | 1.05B |
| Net Income | 782.30M |
| EBITDA | 1.60B |
| EBIT | 1.11B |
| Earnings Per Share (EPS) | $7.93 |
Balance Sheet
The company has $439.60 million in cash and $2.09 billion in debt, with a net cash position of -$1.65 billion or -$16.90 per share.
| Cash & Cash Equivalents | 439.60M |
| Total Debt | 2.09B |
| Net Cash | -1.65B |
| Net Cash Per Share | -$16.90 |
| Equity (Book Value) | 7.20B |
| Book Value Per Share | 73.45 |
| Working Capital | 1.25B |
Cash Flow
In the last 12 months, operating cash flow was $1.34 billion and capital expenditures -$369.00 million, giving a free cash flow of $972.40 million.
| Operating Cash Flow | 1.34B |
| Capital Expenditures | -369.00M |
| Depreciation & Amortization | 486.50M |
| Net Borrowing | -122.00M |
| Free Cash Flow | 972.40M |
| FCF Per Share | $9.98 |
Margins
Gross margin is 44.24%, with operating and profit margins of 18.72% and 13.18%.
| Gross Margin | 44.24% |
| Operating Margin | 18.72% |
| Pretax Margin | 17.64% |
| Profit Margin | 13.18% |
| EBITDA Margin | 26.92% |
| EBIT Margin | 18.72% |
| FCF Margin | 16.38% |
Dividends & Yields
This stock pays an annual dividend of $2.52, which amounts to a dividend yield of 1.24%.
| Dividend Per Share | $2.52 |
| Dividend Yield | 1.24% |
| Dividend Growth (YoY) | 10.53% |
| Years of Dividend Growth | 15 |
| Payout Ratio | 31.78% |
| Buyback Yield | 0.40% |
| Shareholder Yield | 1.65% |
| Earnings Yield | 3.96% |
| FCF Yield | 4.92% |
Analyst Forecast
The average price target for STERIS is $256.86, which is 26.78% higher than the current price. The consensus rating is "Buy".
| Price Target | $256.86 |
| Price Target Difference | 26.78% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 6.60% |
| EPS Growth Forecast (3Y) | 9.19% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 25, 1998. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 25, 1998 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
STERIS has an Altman Z-Score of 5.46 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.46 |
| Piotroski F-Score | 7 |